Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nicotine | 6 | 2024 | 257 | 1.300 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2023 | 147 | 1.230 |
Why?
|
RNA-Binding Proteins | 3 | 2023 | 146 | 1.200 |
Why?
|
Cotinine | 3 | 2020 | 43 | 0.890 |
Why?
|
Endoribonucleases | 1 | 2023 | 23 | 0.880 |
Why?
|
Mice, Obese | 1 | 2020 | 40 | 0.750 |
Why?
|
Fatty Liver | 2 | 2024 | 64 | 0.690 |
Why?
|
Myocytes, Cardiac | 2 | 2020 | 166 | 0.690 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 162 | 0.670 |
Why?
|
Heart | 1 | 2020 | 180 | 0.660 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 52 | 0.650 |
Why?
|
Apoptosis | 3 | 2020 | 1398 | 0.650 |
Why?
|
Myocardium | 1 | 2020 | 235 | 0.640 |
Why?
|
Iridium | 1 | 2017 | 2 | 0.620 |
Why?
|
Acenaphthenes | 1 | 2017 | 2 | 0.620 |
Why?
|
Biomimetic Materials | 1 | 2017 | 23 | 0.610 |
Why?
|
Coordination Complexes | 1 | 2017 | 28 | 0.610 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 1609 | 0.520 |
Why?
|
Smoking | 1 | 2020 | 940 | 0.460 |
Why?
|
Mice | 7 | 2024 | 5913 | 0.430 |
Why?
|
Oxidative Stress | 5 | 2024 | 938 | 0.420 |
Why?
|
Fibroblasts | 2 | 2014 | 272 | 0.390 |
Why?
|
Animals | 14 | 2024 | 15081 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2008 | 213 | 0.340 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2020 | 85 | 0.330 |
Why?
|
Nicotinic Agonists | 2 | 2019 | 75 | 0.330 |
Why?
|
Niacinamide | 1 | 2024 | 15 | 0.240 |
Why?
|
Pyridinium Compounds | 1 | 2024 | 27 | 0.240 |
Why?
|
Primate Diseases | 2 | 2013 | 4 | 0.230 |
Why?
|
Palmitates | 1 | 2023 | 14 | 0.220 |
Why?
|
Hep G2 Cells | 1 | 2023 | 51 | 0.220 |
Why?
|
Picornaviridae Infections | 2 | 2012 | 2 | 0.220 |
Why?
|
Picornaviridae | 2 | 2012 | 4 | 0.220 |
Why?
|
Fatty Acids | 1 | 2023 | 127 | 0.210 |
Why?
|
Male | 7 | 2024 | 20025 | 0.190 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2020 | 42 | 0.190 |
Why?
|
Sanitation | 1 | 2020 | 26 | 0.190 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 58 | 0.180 |
Why?
|
Macaca mulatta | 2 | 2013 | 128 | 0.180 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 146 | 0.180 |
Why?
|
Echocardiography | 1 | 2020 | 144 | 0.180 |
Why?
|
Bangladesh | 6 | 2020 | 20 | 0.170 |
Why?
|
Disease Models, Animal | 3 | 2019 | 1371 | 0.170 |
Why?
|
Heart Ventricles | 1 | 2020 | 110 | 0.170 |
Why?
|
Animals, Newborn | 1 | 2020 | 343 | 0.170 |
Why?
|
Aerosols | 1 | 2019 | 48 | 0.170 |
Why?
|
Mice, Knockout | 2 | 2019 | 933 | 0.170 |
Why?
|
Biopsy, Needle | 1 | 2019 | 60 | 0.170 |
Why?
|
Blotting, Western | 2 | 2019 | 859 | 0.170 |
Why?
|
DNA Damage | 2 | 2014 | 352 | 0.170 |
Why?
|
Random Allocation | 1 | 2019 | 139 | 0.160 |
Why?
|
Stroke Volume | 1 | 2019 | 89 | 0.160 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 96 | 0.160 |
Why?
|
Solar Energy | 1 | 2017 | 9 | 0.150 |
Why?
|
Photochemical Processes | 1 | 2017 | 17 | 0.150 |
Why?
|
Photosynthesis | 1 | 2017 | 29 | 0.150 |
Why?
|
Cations | 1 | 2017 | 45 | 0.150 |
Why?
|
Atherosclerosis | 1 | 2019 | 134 | 0.150 |
Why?
|
Poverty | 1 | 2020 | 348 | 0.150 |
Why?
|
Analysis of Variance | 1 | 2019 | 550 | 0.150 |
Why?
|
Quantum Theory | 1 | 2017 | 78 | 0.150 |
Why?
|
Behavior, Animal | 1 | 2019 | 314 | 0.150 |
Why?
|
RNA, Viral | 3 | 2013 | 301 | 0.140 |
Why?
|
Thermodynamics | 1 | 2017 | 216 | 0.140 |
Why?
|
Immunohistochemistry | 1 | 2019 | 893 | 0.140 |
Why?
|
Ligands | 1 | 2017 | 349 | 0.140 |
Why?
|
Models, Chemical | 1 | 2017 | 207 | 0.140 |
Why?
|
Pregnancy | 1 | 2020 | 1549 | 0.130 |
Why?
|
Feces | 2 | 2012 | 111 | 0.130 |
Why?
|
Humans | 8 | 2023 | 37093 | 0.120 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2014 | 2 | 0.120 |
Why?
|
Simian foamy virus | 1 | 2013 | 1 | 0.120 |
Why?
|
Retroviridae Infections | 1 | 2013 | 3 | 0.120 |
Why?
|
Stromal Cells | 1 | 2014 | 49 | 0.120 |
Why?
|
Proviruses | 1 | 2013 | 29 | 0.120 |
Why?
|
Virus Latency | 1 | 2013 | 42 | 0.110 |
Why?
|
Skin | 1 | 2014 | 174 | 0.110 |
Why?
|
Primates | 1 | 2012 | 36 | 0.110 |
Why?
|
DNA, Mitochondrial | 2 | 2019 | 175 | 0.110 |
Why?
|
Influenza A Virus, H9N2 Subtype | 1 | 2011 | 1 | 0.100 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2011 | 5 | 0.100 |
Why?
|
Influenza in Birds | 1 | 2011 | 8 | 0.100 |
Why?
|
Birds | 1 | 2011 | 28 | 0.100 |
Why?
|
Transcription, Genetic | 1 | 2013 | 578 | 0.090 |
Why?
|
Commerce | 1 | 2011 | 87 | 0.090 |
Why?
|
Genetic Variation | 1 | 2012 | 387 | 0.090 |
Why?
|
Phylogeny | 2 | 2012 | 644 | 0.080 |
Why?
|
Hela Cells | 1 | 2008 | 366 | 0.070 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 59 | 0.070 |
Why?
|
DNA Repair | 1 | 2008 | 188 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 11 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 55 | 0.070 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 191 | 0.070 |
Why?
|
Sequence Analysis, DNA | 3 | 2012 | 474 | 0.060 |
Why?
|
Lipolysis | 1 | 2023 | 18 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2012 | 1568 | 0.060 |
Why?
|
Female | 2 | 2020 | 20969 | 0.060 |
Why?
|
Molecular Epidemiology | 2 | 2012 | 50 | 0.050 |
Why?
|
Serotyping | 2 | 2012 | 36 | 0.050 |
Why?
|
Liver | 1 | 2024 | 479 | 0.050 |
Why?
|
Phenotype | 1 | 2023 | 689 | 0.050 |
Why?
|
Poverty Areas | 1 | 2020 | 41 | 0.050 |
Why?
|
Cytokines | 1 | 2023 | 602 | 0.040 |
Why?
|
Family Characteristics | 1 | 2020 | 108 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2012 | 195 | 0.040 |
Why?
|
Inhalation Exposure | 1 | 2019 | 43 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2019 | 129 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 461 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 1095 | 0.030 |
Why?
|
Gene Products, gag | 1 | 2013 | 12 | 0.030 |
Why?
|
Cheek | 1 | 2013 | 14 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 189 | 0.030 |
Why?
|
Haplorhini | 1 | 2012 | 22 | 0.030 |
Why?
|
Animals, Zoo | 1 | 2012 | 13 | 0.030 |
Why?
|
Viral Structural Proteins | 1 | 2012 | 16 | 0.030 |
Why?
|
Sequence Homology | 1 | 2012 | 34 | 0.030 |
Why?
|
Zoonoses | 1 | 2012 | 17 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 623 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 234 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 229 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 409 | 0.020 |
Why?
|
Hemagglutination | 1 | 2011 | 3 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 278 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 515 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 448 | 0.020 |
Why?
|
Geography | 1 | 2011 | 96 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2014 | 1518 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2014 | 1207 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2014 | 1198 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2007 | 59 | 0.020 |
Why?
|
Models, Genetic | 1 | 2007 | 172 | 0.020 |
Why?
|
Demography | 1 | 2007 | 175 | 0.020 |
Why?
|
Haplotypes | 1 | 2007 | 182 | 0.020 |
Why?
|
DNA Primers | 1 | 2007 | 286 | 0.020 |
Why?
|
Prevalence | 1 | 2011 | 1455 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 803 | 0.020 |
Why?
|
Base Sequence | 1 | 2007 | 997 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 1103 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 677 | 0.010 |
Why?
|